Affiliation
Department ofaMedical Oncology Hematology, The Christie NHS Foundation Trust, Wilmslow Road, Withington, Manchester, UKIssue Date
2014-08
Metadata
Show full item recordCitation
Vemurafenib-induced nonautoimmune haemolytic anaemia. 2014, 24 (4):418-9 Melanoma ResJournal
Melanoma ResearchDOI
10.1097/CMR.0000000000000094PubMed ID
24992630Type
ArticleLanguage
enISSN
1473-5636ae974a485f413a2113503eed53cd6c53
10.1097/CMR.0000000000000094
Scopus Count
Collections
Related articles
- Vitiligo in 2 patients receiving vemurafenib for metastatic melanoma.
- Authors: Alonso-Castro L, Ríos-Buceta L, Vano-Galvan S, Moreno C, Soria-Rivas A, Jaén P
- Issue date: 2013 Jul
- Neutrophilic panniculitis developing after treatment of metastatic melanoma with vemurafenib.
- Authors: Kim GH, Levy A, Compoginis G
- Issue date: 2013 Jul
- Haemorrhage due to proteolysis of FXIII and hyperfibrinolysis under vemurafenib treatment of metastatic melanoma.
- Authors: Trappe R, Budde U, Zimmermann H
- Issue date: 2012 Oct
- Efflorescence of scalp cysts during vemurafenib treatment following brain radiation therapy: a radiation recall dermatitis?
- Authors: Reigneau M, Granel-Brocard F, Geoffrois L, Bauman AS, Tréchot P, Barbaud A, Schmutz JL
- Issue date: 2013 Jul-Aug
- Acquired haemolytic anaemia. II. Drug-induced haemolytic anaemia.
- Authors: Böttiger LE, Westerholm B
- Issue date: 1973 Mar